Bleichroeder’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
LPC
Bleichroeder's DNTH Position: Q1 2023 in Review
Bleichroeder sold out of Dianthus Therapeutics (DNTH) in Q1 2023, closing a stake of 21,664 shares — an estimated $137K sold.
Bleichroeder first reported a position in DNTH in Q1 2020 and held it in 12 quarters. The position peaked at $5.14M in Q1 2021. 52 funds tracked by Wall St. Rank hold DNTH as of Q1 2023.
- Bleichroeder reported no remaining Dianthus Therapeutics position as of Q1 2023 after selling out during the quarter.
- Bleichroeder sold 21,664 Dianthus Therapeutics shares in Q1 2023, an estimated $137K.
- Bleichroeder first reported a position in Dianthus Therapeutics in Q1 2020 and held it in 12 quarters.
- Bleichroeder's Dianthus Therapeutics position peaked at $5.14M in Q1 2021.
- 52 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2023.
Based on Bleichroeder's 13F filing for Q1 2023, filed 12 May 2023.